AI assistant
Bavarian Nordic — Director's Dealing 2021
Apr 17, 2021
3354_rns_2021-04-17_ca49a25c-ed56-464d-9671-0dd0f0cd363d.pdf
Director's Dealing
Open in viewerOpens in your device viewer
BAVARIAN NORDIC
Company Announcement
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, April 17, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company's shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
|---|---|---|---|
| a) | Name | Gerard van Odijk | |
| 2. | Reason for the notification | ||
| a) | Position/status | Chairman of the Board of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Shares | |
| Identification code | DK0015998017 | ||
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 138.43 | 2,709 | ||
| d) | Aggregated information | 2,709 | |
| - Aggregated volume | DKK 375,000.00 | ||
| - Price | |||
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| --- | --- | --- | |
| a) | Name | Anders Gersel Pedersen | |
| 2. | Reason for the notification | ||
| a) | Position/status | Deputy Chairman of the Board of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 |
Bavarian Nordic A/S
Philip Heymans Alle 3
DK-2900 Hellerup
Tel. +45 33 26 83 83
www.bavarian-nordic.com
CVR-no. 16 27 11 87
LEI Code: 2138006JCDVYIN6INP51
Report of transactions of shares and related securities of Bavarian Nordic by persons
holding managerial responsibilities and/or persons/companies closely associated with such
Page 2 of 4
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
|---|---|---|---|
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | Shares | ||
| DK0015998017 | |||
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 138.46 | 1,625 | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | 1,625 | ||
| DKK 225,000.00 | |||
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| --- | --- | --- | --- |
| a) | Name | Erik G. Hansen | |
| 2. | Reason for the notification | ||
| a) | Position/status | Member of the Board of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | ||
| Identification code | Shares | ||
| DK0015998017 | |||
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 138.50 | 1,083 | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | 1,083 | ||
| DKK 150,000.00 | |||
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| --- | --- | --- | |
| a) | Name | Frank Verwiel | |
| 2. | Reason for the notification | ||
| a) | Position/status | Member of the Board of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
Company Announcement no. 15 / 2021
Report of transactions of shares and related securities of Bavarian Nordic by persons
holding managerial responsibilities and/or persons/companies closely associated with such
Page 3 of 4
| a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0015998017 | |
| --- | --- | --- | --- |
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| | | DKK 138.50 | 1,083 |
| d) | Aggregated information
- Aggregated volume
- Price | 1,083
DKK 150,000.00 | |
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | | |
| --- | --- | --- | --- |
| a) | Name | Elizabeth McKee Anderson | |
| 2. | Reason for the notification | | |
| a) | Position/status | Member of the Board of Bavarian Nordic A/S | |
| b) | Initial notification/Amendment | Initial notification | |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | |
| a) | Name | Bavarian Nordic A/S | |
| b) | LEI | 2138006JCDVYIN6INP51 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | |
| a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0015998017 | |
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| | | DKK 138.50 | 1,083 |
| d) | Aggregated information
- Aggregated volume
- Price | 1,083
DKK 150,000.00 | |
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |
| --- | --- | --- |
| a) | Name | Peter Kürstein |
| 2. | Reason for the notification | |
| a) | Position/status | Member of the Board of Bavarian Nordic A/S |
| b) | Initial notification/Amendment | Initial notification |
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | Bavarian Nordic A/S |
| b) | LEI | 2138006JCDVYIN6INP51 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
| a) | Description of the financial instrument, type of instrument | Shares |
Company Announcement no. 15 / 2021
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Page 4 of 4
| Identification code | DK0015998017 | ||
|---|---|---|---|
| b) | Nature of the transaction | Acquisition of shares (vesting of restricted stock units) | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| DKK 138.50 | 1,083 | ||
| d) | Aggregated information | ||
| - Aggregated volume | |||
| - Price | 1,083 | ||
| DKK 150,000.00 | |||
| e) | Date of the transaction | 2021-04-17 | |
| f) | Place of the transaction | Outside a trading venue |
About Bavarian Nordic
Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA under the trade name JYNNEOS®, also for the protection against monkeypox. The vaccine is approved as a smallpox vaccine in Europe under the trade name IMVANEX® and in Canada under the trade name IMVAMUNE®. Our commercial product portfolio furthermore contains the market-leading vaccine Rabipur®/RabAvert® against rabies and Encepur® against tick-borne encephalitis. Using our live virus vaccine platform technology, MVA-BN®, we have created a diverse portfolio of proprietary and partnered product candidates designed to save and improve lives by unlocking the power of the immune system, including an Ebola vaccine, MVABEA®, which is licensed to the Janssen Pharmaceutical Companies of Johnson & Johnson. We are also committed to the development of a next generation COVID-19 vaccine based on an in-licensed capsid virus-like particle technology. The vaccine candidate, ABNCoV2, is currently being investigated in clinical trials. For more information visit www.bavarian-nordic.com.
Contacts
Europe: Rolf Sass Sørensen, Vice President Investor Relations, Tel: +45 61 77 47 43
US: Graham Morrell, Paddock Circle Advisors, [email protected], Tel: +1 781 686 9600
Company Announcement no. 15 / 2021
Company Announcement no. 15 / 2021